logo
Federal cuts for HIV research, prevention and treatment impacting South Florida

Federal cuts for HIV research, prevention and treatment impacting South Florida

Yahoo06-04-2025

Just in the first few months of 2025, Robert Boo's Pride Center discovered four people in Broward County who had HIV through its free testing at churches, festivals, pharmacies and nightclubs.
'If we weren't testing, those four people could spread to four more, and it could quickly start spreading out of control,' Boo said. 'The people spreading it aren't even going to know they are doing it.'
The Pride Center's $350,000 grant for HIV testing runs through June and funding hasn't been renewed yet. With so many federal cuts, it may not be.
'If it isn't renewed, there will be an impact in South Florida,' Boo said, adding that he fears a surge of new cases in Broward County.
South Florida, an area with the highest rate of HIV/AIDS in the country, is already starting to feel the effects of the Trump Administration's federal cuts to funding for research, prevention, and access to treatment for the disease.
Since January, the state's large universities have lost nearly $30 million remaining on terminated federal research grants for studies that include scaling interventions locally to end HIV, reducing risk among Hispanic youth, and increasing prevention (PrEP) enrollment in Latino gay men.
The Florida Department of Health has eliminated positions in its HIV program, including the statewide AIDS drug assistance program patient care director.
Disease surveillance at the state level also is threatened.
'These are the people who oversee statistical reporting of HIV,' said Dr. Elizabeth Sherman, a member of HIV Medicine Association's board of directors and an associate professor of pharmacy practice at Nova Southeastern University. 'It's important to know what populations are seeing upticks of HIV rates so we can focus interventions to those folks. When they cut people who oversee surveillance, it hampers our ability to limit transmission before it starts to spread.'
As of March 24, the Florida Department of Health had been slated to lose $495 million in budgeted funds provided to the state to detect, prevent, and respond to infectious disease outbreaks, including HIV. A federal judge on Thursday temporarily blocked the Trump administration's move to cut that public health funding after 23 states and the District of Columbia sued to keep the funding intact.
Local clinic directors say it's not just funding cuts affecting HIV care: Their foreign-born patients are asking for 90-day prescriptions, telehealth calls, and postponements of blood tests to avoid coming in out of fear of being deported — even when they are in the U.S. legally.
'What is going on with deporting people and making people afraid already has impacts that we are seeing in the clinic,' said Sherman, who helps at a Broward clinic. 'People are not picking up their medications. They are not coming to get their labs drawn. That is how HIV becomes uncontrolled and how it spreads.'
Every day, Sherman talks to people living with HIV who are worried that they will lose access to their life-sustaining medications or insurance should the Ryan White HIV/AIDS Program or Medicaid experience funding cuts. People who have been living with HIV for decades are afraid of returning to the 1980s era when they saw friends dying of AIDS, which occurs at the most advanced stages of infection.
'There's a lot of panic and confusion,' she said. 'Once you break any link in the chain, cut any funding for doctor visits, lab appointments, medications, the whole chain becomes undone and now you have uncontrolled transmission.'
Meanwhile, federal actions do not bode well for eradicating HIV/AIDS or curbing new diagnoses. As of early 2024, more than 128,000 people in Florida are living with HIV — about 59,000 of them in Miami-Dade, Broward, and Palm Beach counties.
On Tuesday, the Trump administration laid off thousands of federal health workers, including teams leading HIV surveillance, prevention, and research and a group of global health researchers working to prevent transmission of HIV from mother to child.
Days earlier, the Administration dismissed the entire staff of the Office of Infectious Disease and HIV Policy, which directed initiatives within the U.S. Department of Health and Human Services, such as the initiative to end the HIV/AIDS epidemic.
The loss of staff and initiatives will trickle down to states like Florida that rely heavily on federal funding for public health initiatives. Florida is one of six states awarded CDC funding dedicated to lowering HIV infections, which helps pay for medicine like pre-exposure prophylactics (PrEP) for at-risk patients.
'Right now, we don't know what cuts will occur at the state level, but I'm sure that's coming soon,' said Joey Wynn, chairman of the South Florida AIDS Network. 'It has everyone on edge.'
Many community programs with HIV services in South Florida are funded through June 30, the end of their fiscal year. Boo at the Pride Center is just one of the organizations uncertain of their future source of funding.
'For now, we are all still operating on money allocated a year ago,' Wynn said. 'The first wave of what we feel here will be in July with the loss of new money.'
Von Biggs, Holy Cross Health Community Health & Well-Being Community Outreach coordinator, said Broward advocates who work to curb HIV transmission regularly battle a lack of education about prevention, the stigma associated with getting tested, and the red tape required to see a doctor and access medication. He still sees young people with new HIV diagnoses, sometimes advanced HIV.
'Our goal is 95-95-95,' he said. 'That means 95% of people who are living with HIV knowing their HIV status, 95% of these people on antiretroviral treatment, and 95% of those on treatment being virally suppressed. We haven't attained our goal yet.'
Biggs believes that private funders and nonprofits will need to step in to fill the void created by any loss of public grants. 'We just need to figure out how to get information into their hands,' he said. 'It has to be a multi-faceted approach, and we have to work it from all angles.'
Even with turmoil at the federal level, Biggs is hopeful that pharmaceutical companies will continue to progress in their trials to eliminate the symptoms of HIV or find a cure.
'I hope in my lifetime to see the end of the HIV epidemic,' he said.
Trials for long-acting injectable medications are promising, including Gilead Sciences' lenacapavir, an injectable drug that protects people for six months with each shot.
In addition, seven people had been cured of AIDS following a stem-cell transplant from a donor carrying genes that are partially resistant to HIV.
In Boca Raton, progress in HIV detection is advancing. Despite federal cutbacks, researchers at Florida Atlantic University received phase 2 of a $1.3 million federal grant in February to develop a low-cost, at-home disposable HIV test.
FAU researcher Waseem Asghar said a challenge in combating HIV is the lack of a self-test that can detect new infections during the first two weeks or identify a rebound in patients on antiviral drugs.
'If the test is easy to do at home, we might be able to fight back and limit transmission,' Asghar said. 'It could be particularly helpful in communities far from a doctor's office.'
Unlike expensive HIV tests today, FAU researchers expect theirs to cost less than $5 each.
Asghar said one in four people in Florida infected with HIV are not on suppressive treatment, so the test could play a significant role in helping them learn their status.
Acknowledging the recent cuts to federal research funding, Asghar said his grant shows HIV is still an important area of study.
South Florida Sun Sentinel health reporter Cindy Goodman can be reached at cgoodman@sunsentinel.com or on X @cindykgoodman.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

U.S. aid cuts leave $11 million in birth control supplies for Sub-Saharan Africa stranded
U.S. aid cuts leave $11 million in birth control supplies for Sub-Saharan Africa stranded

Business Insider

timean hour ago

  • Business Insider

U.S. aid cuts leave $11 million in birth control supplies for Sub-Saharan Africa stranded

Millions of contraceptives intended to support women across Africa are reportedly sitting idle in warehouses and are at risk of being destroyed due to delays and funding cuts from the United States government. Millions of contraceptives intended for Africa are at risk of expiration due to U.S. government delays and funding cuts. The supplies, valued at $11 million, include various contraceptive tools meant for low-income countries. The delayed distribution may lead to increased health risks and strain on the healthcare systems in Africa. A former US official and aid worker revealed that the contraceptives, valued at around $11 million, include condoms, birth control pills, implants, and intrauterine devices (IUDs), which were originally intended to help women in low-income countries, particularly in sub-Saharan Africa, avoid unplanned pregnancies and protect themselves from sexually transmitted infections like HIV. However, the supplies are now stuck in storage facilities in Belgium and Dubai. According to sources at Reuters, the U.S. The Agency for International Development (USAID) has decided not to pay for their delivery and is no longer donating them as part of foreign aid programs. This delay stems from policy changes implemented by the former U.S. President Donald Trump, who reduced foreign assistance under his 'America First' approach: USAID gives update A recent internal memo from USAID, dated April, highlighted the urgent need to transfer the stock to prevent waste and minimize further costs. Despite this warning, a concrete plan has yet to be announced. With each passing month, the contraceptives edge closer to expiration. A senior U.S. State Department officials further confirmed that the contraceptives remain in storage, but no final decision has been made regarding their fate. The situation, according to the US official, is both frustrating and urgent for many health workers and aid groups. Another former USAID official said the stalled shipment represents nearly 20% of all contraceptives the U.S. usually donates each year, adding that if no solution is found soon, the entire stock could be destroyed, at a cost of hundreds of thousands of dollars. 'These supplies were meant to help women who have little or no access to family planning—girls fleeing conflict, mothers in refugee camps, and young women at risk of early pregnancy, ' one source said. ' The condoms in the shipment were also meant to help prevent the spread of HIV, which continues to impact millions across the region.' It added. Karen Hong, head of supply chain at the United Nations Population Fund (UNFPA), said her team is already working on an alternative plan. ' We cannot dwell on an issue for too long; when urgency and clarity don't align, we have to move on,' she said.

Graphs that paint the picture of HIV in SA
Graphs that paint the picture of HIV in SA

News24

time4 hours ago

  • News24

Graphs that paint the picture of HIV in SA

Eight million people are living with HIV with more than six million being on treatment. Behind these big numbers lurk a universe of fascinating epidemiological dynamics. In this special briefing, Spotlight editor Marcus Low unpacks what we know about the state of HIV in South Africa. This is part 1 of 3. Four decades ago, hardly anyone in South Africa had HIV. Today, roughly one in eight people here are living with the virus. HIV has quite simply become a routine part of life in South Africa. But thanks to the fact that antiretroviral treatment is keeping several million people alive, HIV is no longer the crisis it was at the turn of the century. For many, the virus is still an all-too-real part of their lives. It still ranks among the country's top killers. As we will see in this Spotlight special briefing, there is good and bad news. We have made massive progress in our collective fight against HIV, especially since around 2008. But, as positive as the big picture may be, there are also reasons to be worried. In the 10 sections of this special briefing, we have used lots of graphs and an interactive table to liven things up. We have drawn almost entirely on estimates from Thembisa, the leading mathematical model of HIV in South Africa and also the basis for UNAIDS' country numbers. The big picture Total PLHIV in SA Graphic: Spotlight South Africa has the world's biggest HIV epidemic. Eight million people, or 12.8% of the population, lived with the virus in 2024. Despite the massive progress we've made in the last 20 years, this absolute number has kept increasing, and, at least by this measure, the epidemic has kept getting bigger. But while more people are living with HIV, dramatically fewer people are dying of HIV-related causes than two decades ago - we've gone from 281 000 HIV-related deaths in 2005/06 to 53 000 in 2023/24. This is mainly because antiretroviral medicines have kept several million people alive who would otherwise now be dead. The rate of new infections has also declined a lot, as shown in the above graph. South Africa's HIV epidemic is closely entwined with our tuberculosis (TB) epidemic. This is because untreated HIV breaks down the immune system, which then makes people vulnerable to falling ill with TB. Accordingly, TB is the top cause of HIV-related deaths in South Africa. Recovering life expectancy Just what a big deal HIV has been in South Africa is clear from estimates of life expectancy in the country. As HIV killed more and more people through the nineties and early 2000s, life expectancy dropped precipitously from 63.2 in 1990 to 53.2 in 2004. But then, as antiretroviral treatment started keeping more and more people alive, it increased again. It stood at 66.1 in 2024. Graphic: Spotlight There is much history that is not captured in this graph. Perhaps most notably, the introduction of antiretroviral treatment in South Africa's public sector was intentionally delayed by the state's policy of Aids denialism under then-president Thabo Mbeki. While the dramatic improvement from 2005 onward is impressive, life expectancy didn't have to drop as low as it did in the first place. The blip you can see on the right of the graph is a result of the Covid-19 pandemic. While significant, the broader trend is driven by HIV and the recovery from HIV. A massive treatment programme Of the eight million people living with HIV in South Africa, about 6.2 million or roughly four in five, were on treatment in 2024. This means South Africa has the world's most extensive HIV treatment programme by some distance. We take it somewhat for granted these days, but to treat so many people is a tremendous success story for which many healthcare workers, activists, government officials, donors, and others deserve great credit. That said, it is concerning that about one in five people with the virus are not on treatment. Treatment is recommended for everyone living with the virus. Though we focus on treatment coverage here, these numbers are often split further into the UNAIDS 95-95-95 targets. READ | Trump's HIV funding cuts will hit diabetes and cervical cancer treatment hard. Here's why In 2024, 95% of people living with HIV had been diagnosed, 81.5% of those diagnosed were on treatment, and 92% of those on treatment were virally suppressed - meaning the amount of virus in their blood was below a low threshold. The key takeaway from these numbers is that the most significant gap in South Africa's HIV response is in helping people who have already been diagnosed to start and stay on treatment. *Check back tomorrow for part 2 of this series. You can also find the complete version of this #InTheSpotlight special briefing as a single page on the Spotlight website. Note: All of the above graphs are based on outputs from version 4.8 of the Thembisa model published in March 2025. We thank the Thembisa team for sharing their outputs so freely. Graphs were produced by Spotlight using the R package ggplot2. You are free to reuse and republish the graphs. For ease of use, you can download them as a Microsoft PowerPoint slide deck. Technical note: The Thembisa model outputs include both stock and flow variables. This is why we have at some places written 2024 (for stock variables) and 2023/2024 (for flow variables). 2024 should be read as mid-2024. 2023/2024 should be read as the period from mid-2023 to mid-2024.

Can Tackling Addictions Reduce Medicaid Costs?
Can Tackling Addictions Reduce Medicaid Costs?

Newsweek

time12 hours ago

  • Newsweek

Can Tackling Addictions Reduce Medicaid Costs?

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Discussions around Medicaid costs have become more heated than ever in recent months as President Donald Trump's administration tries to push its budget bill through the legislative ranks. House Republicans have instructed the House Committee on Energy and Commerce to slash $880 billion in spending over the next decade, with Medicaid making up 93 percent of the committee's budget. As a result, the amount of money the federal Medicaid program needs to provide health care services for more than 70 million Americans has been under dispute, with some arguing there is significant waste and misuse of money in the system, while others have warned cuts would leave millions of vulnerable people without access to health care. While lawmakers continue debating the divisive legislation, experts have discussed with Newsweek whether there could be another way of reducing Medicaid costs—tackling substance use disorders. Medicaid enrollees with substance use disorders require significantly higher health costs than those without—around $1,200 per month on average compared to $550, according to KFF. Around 7.2 percent of Medicaid recipients age 12 to 64 have a diagnosed substance use disorder, and treatment is key to addressing overdoses, deaths and other health or social complications, KFF reported. So could tackling substance use disorders in turn reduce costs for the Medicaid program? Here's what experts told Newsweek. Photo-illustration by Newsweek/Getty/Canva Why Are Medicaid Costs Higher for Those With Substance Use Disorders? The reason Medicaid enrollees with substance use disorders have higher health costs is because they often also have additional health complications, Dr. Joshua Lynch, professor of emergency and addiction medicine at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, New York, told Newsweek. This could be physical health conditions, such as hypertension, high cholesterol and diabetes, or mental health disorders, "which can lead to more complex health care needs," he added. Those with substance use disorders also may "experience more fragmented care and more challenging access to high quality, lower cost care and preventative services," Lynch said. They may also struggle to work, or stay in work, and this may "contribute to increased reliance on higher-cost healthcare services," he added. Many Americans with substance use disorders also go undiagnosed, Brendan Saloner, professor of health policy and management at the John Hopkins Bloomberg School of Public Health, Maryland, told Newsweek. He added that those with substance addiction can have a lot of problems, such as the risk of overdose, or contracting blood-borne diseases like HIV or hepatitis C, as well as other issues, so "it's much better to get people into care proactively then to wait for their problems to become a crisis." The higher costs for those with substance use disorders, therefore, could "reflect the devastating physical consequences of substance use itself," Heidi Allen, professor of social work at the Columbia University School of Social Work, New York, told Newsweek, pointing to overdoses, increased vulnerability for chronic illness and exposure to infectious diseases. It's also not just about health complications, John Kelly, professor of psychiatry at Harvard Medical School and director of the Recovery Research Institute at Massachusetts General Hospital, told Newsweek. "The nature of these disorders means also that, on average, in the Medicaid population, individuals suffering from substance use disorder tend to have more social instability in terms of secure housing, employment, and criminal justice complications. These all contribute to increased costs," he said. Could Tackling Substance Use Disorders Reduce Medicaid Costs? While tackling substance use disorders may not slash Medicaid costs in the short term, as it would require investment in prevention and treatment, it could have positive economic impacts in the long run. "Prioritizing substance use treatment for enrollees might not reduce Medicaid costs in the short term, since we would expect more Medicaid enrollees to engage with treatment, which itself costs money," Allen said. However, she added that "it could certainly improve the health of enrollees, which might result in Medicaid savings down the road." If patients also have access to high-quality treatment and are able to manage their condition, "they have a lower reliance on high-cost health care such as emergency visits and inpatient hospitalizations," Lynch said. He added that other comorbidities also become more manageable, while housing stability and employment turn more achievable. "All of these will lead to a decrease in overall Medicaid spending," he said. Kelly also said he thought that tackling substance use disorders could reduce costs for Medicaid, adding that "focus on earlier intervention, and better implementation of care coordination will result in reduced use of more expensive acute medical care services, as well as prevention of the contraction of more chronic disease such as alcohol-associated liver diseases, HIV and hepatitis infections." "I am very confident that it would help to prevent some long-term costs to the program and would have a huge impact on other non-health needs like employment and reduced incarceration," Saloner said. But he added that whether it fully pays for itself, or saves money, is a more difficult question to answer. "We have some older studies showing that substance use care can offset lots of costs to society, but purely from the perspective of the Medicaid budget it's hard to say. The quality of life gains make it very cost-effective, whether or not it's cost saving," he said. Carrie Fry, professor in the department of health policy at Vanderbilt University School of Medicine, Tennessee, told Newsweek: "Research shows that addressing substance use disorder with effective, evidence-based treatments reduces Medicaid costs." In order to cut Medicaid costs, Fry said, making it easier for people with substance use disorders "to start and remain on effective treatment" would be an important step in the process. "For opioid use disorder, this means expanding availability of medications for opioid use disorder including methadone, buprenorphine, and naltrexone," she said. She added that only about half of Medicaid enrollees with an opioid use disorder receive evidence-based treatment in a given year. "So, treatment is an important first step to addressing the burden of substance use disorders in Medicaid and can reduce or prevent additional downstream costs," Fry said. She added that reducing the prevalence of substance use disorder via prevention will "require a more comprehensive approach to addressing broader social conditions that lead to increased risk of developing a substance use disorder."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store